The impact of PSMA PET on the treatment and outcomes of men with biochemical recurrence of prostate cancer: a systematic review and meta-analysis
A Pozdnyakov, R Kulanthaivelu, G Bauman… - Prostate Cancer and …, 2023 - nature.com
Background Prostate-specific membrane antigen (PSMA) PET is highly sensitive in
identifying disease recurrence in men with biochemical recurrence of prostate cancer (BCR) …
identifying disease recurrence in men with biochemical recurrence of prostate cancer (BCR) …
Use of gallium‐68 prostate‐specific membrane antigen positron‐emission tomography for detecting lymph node metastases in primary and recurrent prostate cancer …
HB Luiting, PJ van Leeuwen, MB Busstra… - BJU …, 2020 - Wiley Online Library
Objectives To review the literature to determine the sensitivity and specificity of gallium‐68
prostate‐specific membrane antigen (68Ga‐PSMA) positron‐emission tomography (PET) for …
prostate‐specific membrane antigen (68Ga‐PSMA) positron‐emission tomography (PET) for …
Impact of 68Ga-PSMA-11 PET/CT on staging and management of prostate cancer patients in various clinical settings: a prospective single-center study
I Sonni, M Eiber, WP Fendler, RM Alano… - Journal of Nuclear …, 2020 - Soc Nuclear Med
The impact of prostate-specific membrane antigen (PSMA) PET/CT on management of
prostate cancer (PCa) patients with biochemical recurrence (BCR) is well established …
prostate cancer (PCa) patients with biochemical recurrence (BCR) is well established …
Diagnostic performance and clinical impact of 68Ga-PSMA-11 PET/CT imaging in early relapsed prostate cancer after radical therapy: a prospective multicenter study …
Biochemical recurrence (BCR) is a clinical challenge in prostate cancer (PCa) patients, as
recurrence localization guides subsequent therapies. The use of PET with prostate-specific …
recurrence localization guides subsequent therapies. The use of PET with prostate-specific …
The impact of positron emission tomography imaging and tumor molecular profiling on risk stratification, treatment choice, and oncological outcomes of patients with …
Context The clinical introduction of next-generation imaging methods and molecular
biomarkers (“radiogenomics”) has revolutionized the field of prostate cancer (PCa). While …
biomarkers (“radiogenomics”) has revolutionized the field of prostate cancer (PCa). While …
PSMA-targeted Radiotracers versus 18F Fluciclovine for the Detection of Prostate Cancer Biochemical Recurrence after Definitive Therapy: A …
N Tan, U Oyoyo, N Bavadian, N Ferguson… - Radiology, 2020 - pubs.rsna.org
Background National guidelines endorse fluorine 18 (18F) fluciclovine PET/CT for the
detection of prostate cancer (PCa) in men with biochemically recurrent PCa. The …
detection of prostate cancer (PCa) in men with biochemically recurrent PCa. The …
Head-to-head comparison of 68Ga-PSMA-11 PET/CT and 68Ga-PSMA-11 PET/MRI in the detection of biochemical recurrence of prostate cancer: summary of head …
H Huo, S Shen, D He, B Liu, F Yang - Prostate Cancer and Prostatic …, 2023 - nature.com
Purpose Our meta-analysis aimed to evaluate the diagnostic performance of 68Ga-PSMA-
11 PET/CT vs. 68Ga-PSMA-11 PET/MRI for biochemical recurrence of prostate cancer …
11 PET/CT vs. 68Ga-PSMA-11 PET/MRI for biochemical recurrence of prostate cancer …
Comparing the diagnostic performance of radiotracers in prostate cancer biochemical recurrence: a systematic review and meta-analysis
W Ma, J Mao, J Yang, T Wang, ZH Zhao - European Radiology, 2022 - Springer
Objectives To systematically assess the early detection rate of biochemical prostate cancer
recurrence using choline, fluciclovine, and PSMA. Methods Under the guidance of the …
recurrence using choline, fluciclovine, and PSMA. Methods Under the guidance of the …
Effects of 225Ac-labeled prostate-specific membrane antigen radioligand therapy in metastatic castration-resistant prostate cancer: a meta-analysis
DY Lee, Y Kim - Journal of Nuclear Medicine, 2022 - Soc Nuclear Med
Prostate-specific membrane antigen (PSMA), overexpressed in prostate cancer, has
become a popular target for radionuclide-based theranostic applications in the advanced …
become a popular target for radionuclide-based theranostic applications in the advanced …
Management of patients with recurrent and metachronous oligometastatic prostate cancer in the era of PSMA PET
Simple Summary Prostate-specific membrane antigen positron emission tomography (PSMA
PET) is a modern imaging modality used in the management of patients with prostate cancer …
PET) is a modern imaging modality used in the management of patients with prostate cancer …